Preparation and use of a stable, inactivated Rift Valley fever antigen.
D000914:Antibodies, Viral; D000956:Antigens, Viral / Q000302:isolation & purification; D001103:Arboviruses / Q000276:immunology*; D006389:Hemagglutinins, Viral; D006801:Humans; D006863:Hydrogen-Ion Concentration; D011420:Propiolactone; D012296:Rift Valley fever virus / Q000276:immunology*; D013696:Temperature; D014357:Trypsin; D014611:Vaccination; D014765:Viral Vaccines
D000914:Antibodies, Viral; D000956:Antigens, Viral; D006389:Hemagglutinins, Viral; D014765:Viral Vaccines; D011420:Propiolactone; D014357:Trypsin